Search Results

There are 1011 results for: content related to: Low rates of naturally occurring resistant variants to the NS5A inhibitor daclatasvir in HCV-1 null responders

  1. You have free access to this content
    Deep sequencing analysis of variants resistant to the non-structural 5A inhibitor daclatasvir in patients with genotype 1b hepatitis C virus infection

    Hepatology Research

    Volume 44, Issue 14, December 2014, Pages: E360–E367, Mika Miura, Shinya Maekawa, Mitsuaki Sato, Nobutoshi Komatsu, Akihisa Tatsumi, Shinichi Takano, Fumitake Amemiya, Yasuhiro Nakayama, Taisuke Inoue, Minoru Sakamoto and Nobuyuki Enomoto

    Article first published online : 10 APR 2014, DOI: 10.1111/hepr.12316

  2. You have free access to this content
    Review article: the efficacy and safety of daclatasvir in the treatment of chronic hepatitis C virus infection

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 3, August 2015, Pages: 258–272, C. Bunchorntavakul and K. R. Reddy

    Article first published online : 27 MAY 2015, DOI: 10.1111/apt.13264

  3. You have free access to this content
    Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevir

    Hepatology

    Volume 58, Issue 3, September 2013, Pages: 902–911, Fiona McPhee, Dennis Hernandez, Fei Yu, Joseph Ueland, Aaron Monikowski, Arlene Carifa, Paul Falk, Chunfu Wang, Robert Fridell, Timothy Eley, Nannan Zhou and David Gardiner

    Article first published online : 16 JUL 2013, DOI: 10.1002/hep.26388

  4. Development of antiviral drugs for the treatment of hepatitis C at an accelerating pace

    Reviews in Medical Virology

    Volume 25, Issue 4, July 2015, Pages: 254–267, Erik De Clercq

    Article first published online : 4 JUN 2015, DOI: 10.1002/rmv.1842

  5. Long term persistence of NS5A inhibitor-resistant hepatitis C virus in patients who failed daclatasvir and asunaprevir therapy

    Journal of Medical Virology

    Satoshi Yoshimi, Michio Imamura, Eisuke Murakami, Nobuhiko Hiraga, Masataka Tsuge, Yoshiiku Kawakami, Hiroshi Aikata, Hiromi Abe, C. Nelson Hayes, Tamito Sasaki, Hidenori Ochi and Kazuaki Chayama

    Article first published online : 16 JUN 2015, DOI: 10.1002/jmv.24255

  6. Current prospects for interferon-free treatment of hepatitis C in 2012

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 1, January 2013, Pages: 38–45, Catherine AM Stedman

    Article first published online : 19 DEC 2012, DOI: 10.1111/jgh.12028

  7. Novel Therapeutic Approaches for Hepatitis C

    Clinical Pharmacology & Therapeutics

    Volume 95, Issue 1, January 2014, Pages: 78–88, JS Au and PJ Pockros

    Article first published online : 19 DEC 2013, DOI: 10.1038/clpt.2013.206

  8. Hepatitis C therapy in non-genotype 1 patients: the near future

    Journal of Viral Hepatitis

    Volume 19, Issue 8, August 2012, Pages: 525–536, C. Wartelle-Bladou, G. Le Folgoc, M. Bourlière and L. Lecomte

    Article first published online : 4 JUL 2012, DOI: 10.1111/j.1365-2893.2012.01634.x

  9. You have free access to this content
    Reply:

    Hepatology

    Volume 57, Issue 5, May 2013, Pages: 2087–2088, Jin-Hua Sun, Min Gao, Susan Roberts and Robert Fridell

    Article first published online : 23 APR 2013, DOI: 10.1002/hep.26381

  10. You have free access to this content
    Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b–infected null responders

    Hepatology

    Volume 55, Issue 3, March 2012, Pages: 742–748, Kazuaki Chayama, Shoichi Takahashi, Joji Toyota, Yoshiyasu Karino, Kenji Ikeda, Hiroki Ishikawa, Hideaki Watanabe, Fiona McPhee, Eric Hughes and Hiromitsu Kumada

    Article first published online : 30 JAN 2012, DOI: 10.1002/hep.24724

  11. You have full text access to this OnlineOpen article
    Emerging therapies for the treatment of hepatitis C

    EMBO Molecular Medicine

    Volume 6, Issue 1, January 2014, Pages: 4–15, Christian M Lange, Ira M Jacobson, Charles M Rice and Stefan Zeuzem

    Article first published online : 16 SEP 2013, DOI: 10.1002/emmm.201303131

  12. You have free access to this content
    Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation

    Liver Transplantation

    Volume 18, Issue 9, September 2012, Pages: 1053–1059, Robert J. Fontana, Eric A. Hughes, Henry Appelman, Robert Hindes, Dessislava Dimitrova and Marc Bifano

    Article first published online : 27 AUG 2012, DOI: 10.1002/lt.23482

  13. Emergence of resistant variants detected by ultra-deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1

    Journal of Viral Hepatitis

    Volume 22, Issue 2, February 2015, Pages: 158–165, K. Kosaka, M. Imamura, C. N. Hayes, H. Abe, N. Hiraga, S. Yoshimi, E. Murakami, T. Kawaoka, M. Tsuge, H. Aikata, D. Miki, H. Ochi, H. Matsui, A. Kanai, T. Inaba and K. Chayama

    Article first published online : 19 JUN 2014, DOI: 10.1111/jvh.12271

  14. You have free access to this content
    Poster Session 4: Hepatitis C: New Agents (Not Approved)

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1128A–1161A,

    Article first published online : 1 OCT 2014, DOI: 10.1002/hep.27533

  15. Interferon-α/β for treatment of chronic hepatitis C infection in the era of direct-acting antiviral agents

    Hepatology Research

    Volume 44, Issue 4, April 2014, Pages: 371–376, Masaru Enomoto, Akihiro Tamori, Yoshiki Murakami and Norifumi Kawada

    Article first published online : 23 JAN 2014, DOI: 10.1111/hepr.12289

  16. You have free access to this content
    New horizons in hepatitis C antiviral therapy with direct-acting antivirals

    Hepatology

    Volume 58, Issue 1, July 2013, Pages: 428–438, Alessio Aghemo and Raffaele De Francesco

    Article first published online : 31 MAY 2013, DOI: 10.1002/hep.26371

  17. Safe and effective treatment with daclatasvir and asunaprevir in a liver transplant recipient with severe cholestatic hepatitis C

    Hepatology Research

    Yoshihide Ueda, Toshimi Kaido, Etsuro Hatano, Shigeru Ohtsuru and Shinji Uemoto

    Article first published online : 27 APR 2015, DOI: 10.1111/hepr.12509

  18. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Article first published online : 1 OCT 2012, DOI: 10.1002/hep.26040

  19. Hepatitis C virus drug resistance–associated substitutions: State of the art summary

    Hepatology

    Erik Lontok, Patrick Harrington, Anita Howe, Tara Kieffer, Johan Lennerstrand, Oliver Lenz, Fiona McPhee, Hongmei Mo, Neil Parkin, Tami Pilot-Matias and Veronica Miller

    Article first published online : 30 JUL 2015, DOI: 10.1002/hep.27934

  20. You have free access to this content
    Preclinical Pharmacokinetics and In Vitro Metabolism of Asunaprevir (BMS-650032), a Potent Hepatitis C Virus NS3 Protease Inhibitor

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 9, September 2015, Pages: 2813–2823, Kathleen W. Mosure, Jay O. Knipe, Marc Browning, Vinod Arora, Yue-Zhong Shu, Thomas Phillip, Fiona Mcphee, Paul Scola, Anand Balakrishnan, Matthew G. Soars, Kenneth Santone and Michael Sinz

    Article first published online : 28 JAN 2015, DOI: 10.1002/jps.24356